M Roth1, L Daas2, A Renner-Wilde3, N Cvetkova-Fischer4, M Saeger5, M Herwig-Carl6, M Matthaei7, A Fekete8, V Kakkassery8,9, G Walther10, M von Lilienfeld-Toal10,11, C Mertens12, J Lenk13, J Mehlan14, C Fischer15, M Fuest16, S Kroll17, W Bayoudh18, A Viestenz2,19, A Frings20, C R MacKenzie21, E M Messmer3, B Seitz2, O Kurzai10,22, G Geerling20. 1. Klinik für Augenheilkunde, Universitätsaugenklinik Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland. mathiasroth@gmx.net. 2. Klinik für Augenheilkunde, Universitätsklinikum des Saarlandes UKS, Homburg/Saar, Deutschland. 3. Augenklinik des Klinikums der Universität München, Ludwig-Maximilians Universität München, München, Deutschland. 4. Klinik für Augenheilkunde, Universitätsklinikum Regensburg, Regensburg, Deutschland. 5. Klinik für Ophthalmologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Deutschland. 6. Universitätsaugenklinik, Universitätsklinikum Bonn, Bonn, Deutschland. 7. Zentrum für Augenheilkunde, Uniklinik Köln, Köln, Deutschland. 8. Klinik und Poliklinik für Augenheilkunde, Universitätsmedizin Rostock, Rostock, Deutschland. 9. Klinik für Augenheilkunde, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Lübeck, Deutschland. 10. Nationales Referenzzentrum für Invasive Pilzinfektionen NRZMyk, Leibniz Institut für Naturstoff-Forschung und Infektionsbiologie - Hans-Knöll-Institut, Jena, Deutschland. 11. Medizinische Klinik II, Abteilung für Hämatologie und internistische Onkologie, Universitätsklinikum Jena, Jena, Deutschland. 12. Augenklinik Marzahn, Berlin, Deutschland. 13. Klinik für Augenheilkunde, Universitätsklinikum Carl Gustav Carus Dresden, Dresden, Deutschland. 14. Klinik für Augenheilkunde, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Deutschland. 15. Augenklinik, Universitätsmedizin Göttingen, Göttingen, Deutschland. 16. Klinik für Augenheilkunde, Uniklinik RWTHA Aachen, Aachen, Deutschland. 17. Ernst von Bergmann Klinikum, Potsdam, Deutschland. 18. Augenklinik, Klinikum Dortmund, Dortmund, Deutschland. 19. Klinik für Augenheilkunde, Universitätsklinikum Halle (Saale), Halle (Saale), Deutschland. 20. Klinik für Augenheilkunde, Universitätsaugenklinik Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland. 21. Institut für Medizinische Mikrobiologie und Krankenhaushygiene, Universitätsklinikum Düsseldorf, Düsseldorf, Deutschland. 22. Institut für Hygiene und Mikrobiologie, Universität Würzburg, Würzburg, Deutschland.
Abstract
BACKGROUND AND PURPOSE: Mycotic keratitis is a serious but relatively rare disease. No targeted data collection in Germany existed until the foundation of the German Pilz-Keratitis Register in 2015. PATIENTS AND METHODS: The inclusion of retrospective and prospective patients was carried out. INCLUSION CRITERIA: diagnosis confirmed by the polymerase chain reaction (PCR), culture, histology or confocal microscopy (IVCM). Collected parameters: date of symptom onset, date and method of diagnosis, risk factors, visual acuity and findings at admission and at follow-up, conservative and surgical treatment. RESULTS: By January 2018, a total of 102 eyes from the years 2000-2017 were reported from 16 centers (64.3% female, mean age 52 years, range 18-95 years). The initial diagnosis was made correctly in only 20.6% of cases. The mean time to correct diagnosis was 31.7 ± 46.9 (0-296) days. The diagnosis was confirmed in cultures in 74.5%, histologically in 30.4%, by PCR in 38.2% and IVCM in 27.4%. Fungal species identified were: 36.7% Fusarium spp., 35.8% Candida spp., 6.4% Aspergillus spp. and 21.1% other. The most important risk factor was the use of contact lenses. The most commonly used antifungal agent was voriconazole (64.7%) followed by amphotericin B (37.2%). Penetrating keratoplasty was performed in 65.7% of the cases and 8.8% of the affected eyes had to be enucleated. The visual acuity of the entire study population increased from the initial 0.16 ± 0.25 (0.001-1.0) decimal to 0.28 ± 0.34 (0-1.0) decimal. CONCLUSION: The correct diagnosis of fungal keratitis is often significantly delayed. The treatment can be very difficult and keratoplasty is often necessary. In order to gain a better understanding of this disease, to recognize previously unknown risk factors and, if necessary, a change in the spectrum of pathogens and to identify approaches to treatment optimization, the fungal keratitis registry will be continued.
BACKGROUND AND PURPOSE:Mycotic keratitis is a serious but relatively rare disease. No targeted data collection in Germany existed until the foundation of the German Pilz-Keratitis Register in 2015. PATIENTS AND METHODS: The inclusion of retrospective and prospective patients was carried out. INCLUSION CRITERIA: diagnosis confirmed by the polymerase chain reaction (PCR), culture, histology or confocal microscopy (IVCM). Collected parameters: date of symptom onset, date and method of diagnosis, risk factors, visual acuity and findings at admission and at follow-up, conservative and surgical treatment. RESULTS: By January 2018, a total of 102 eyes from the years 2000-2017 were reported from 16 centers (64.3% female, mean age 52 years, range 18-95 years). The initial diagnosis was made correctly in only 20.6% of cases. The mean time to correct diagnosis was 31.7 ± 46.9 (0-296) days. The diagnosis was confirmed in cultures in 74.5%, histologically in 30.4%, by PCR in 38.2% and IVCM in 27.4%. Fungal species identified were: 36.7% Fusarium spp., 35.8% Candida spp., 6.4% Aspergillus spp. and 21.1% other. The most important risk factor was the use of contact lenses. The most commonly used antifungal agent was voriconazole (64.7%) followed by amphotericin B (37.2%). Penetrating keratoplasty was performed in 65.7% of the cases and 8.8% of the affected eyes had to be enucleated. The visual acuity of the entire study population increased from the initial 0.16 ± 0.25 (0.001-1.0) decimal to 0.28 ± 0.34 (0-1.0) decimal. CONCLUSION: The correct diagnosis of fungal keratitis is often significantly delayed. The treatment can be very difficult and keratoplasty is often necessary. In order to gain a better understanding of this disease, to recognize previously unknown risk factors and, if necessary, a change in the spectrum of pathogens and to identify approaches to treatment optimization, the fungal keratitis registry will be continued.
Authors: Thomas Gaujoux; Enwar Borsali; Pablo Goldschmidt; Christine Chaumeil; Christophe Baudouin; Jean Philippe Nordmann; José Alain Sahel; Laurent Laroche; Vincent M Borderie Journal: Acta Ophthalmol Date: 2011-03 Impact factor: 3.761
Authors: Emily W Gower; Lisa J Keay; Rafael A Oechsler; Alfonso Iovieno; Eduardo C Alfonso; Dan B Jones; Kathryn Colby; Sonal S Tuli; Seema R Patel; Salena M Lee; John Irvine; R Doyle Stulting; Thomas F Mauger; Oliver D Schein Journal: Ophthalmology Date: 2010-06-29 Impact factor: 12.079
Authors: N Venkatesh Prajna; Tiruvengada Krishnan; Revathi Rajaraman; Sushila Patel; Muthiah Srinivasan; Manoranjan Das; Kathryn J Ray; Kieran S O'Brien; Catherine E Oldenburg; Stephen D McLeod; Michael E Zegans; Travis C Porco; Nisha R Acharya; Thomas M Lietman; Jennifer Rose-Nussbaumer Journal: JAMA Ophthalmol Date: 2016-12-01 Impact factor: 7.389
Authors: Jan Springer; Grit Walther; Volker Rickerts; Axel Hamprecht; Birgit Willinger; Daniel Teschner; Hermann Einsele; Oliver Kurzai; Juergen Loeffler Journal: J Fungi (Basel) Date: 2019-11-12
Authors: Alexander M Aldejohann; Johanna Theuersbacher; Lukas Haug; Olga S Lamm; Grit Walther; Oliver Kurzai; Jost Hillenkamp; Daniel Kampik Journal: Med Mycol Case Rep Date: 2021-02-12
Authors: Grit Walther; Anna Zimmermann; Johanna Theuersbacher; Kerstin Kaerger; Marie von Lilienfeld-Toal; Mathias Roth; Daniel Kampik; Gerd Geerling; Oliver Kurzai Journal: J Fungi (Basel) Date: 2021-06-26